Exane Derivatives’s Rio Tinto RIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,892
Closed -$1.04M 890
2022
Q1
$1.04M Sell
12,892
-27,563
-68% -$2.09M 0.29% 89
2021
Q4
$2.71M Buy
40,455
+10,183
+34% +$659K 0.66% 24
2021
Q3
$2.02M Buy
30,272
+6,477
+27% +$505K 0.49% 37
2021
Q2
$2.03M Sell
23,795
-13,896
-37% -$1.19M 0.46% 41
2021
Q1
$2.93M Buy
37,691
+18,130
+93% +$1.49M 0.84% 26
2020
Q4
$1.47M Buy
+19,561
New +$1.28M 0.43% 47
2019
Q1
Sell
-83,400
Closed -$4.04M 706
2018
Q4
$4.04M Buy
83,400
+83,371
+287,486% +$4.07M 0.73% 29
2018
Q3
$1.48K Sell
29
-31,972
-100% -$1.63M ﹤0.01% 513
2018
Q2
$1.79M Sell
32,001
-44,505
-58% -$2.49M 0.3% 79
2018
Q1
$3.84M Buy
76,506
+34,504
+82% +$1.88M 0.77% 23
2017
Q4
$2.22M Buy
42,002
+42,001
+4,200,100% +$2.05M 0.38% 45
2017
Q3
$47 Sell
1
-13,109
-100% -$609K ﹤0.01% 539
2017
Q2
$555K Buy
+13,110
New +$526K 0.12% 130
2017
Q1
Sell
-98,873
Closed -$3.8M 660
2016
Q4
$3.8M Buy
+98,873
New +$3.63M 0.75% 43
2016
Q3
Sell
-16,668
Closed -$531K 652
2016
Q2
$522K Buy
+16,668
New +$498K 0.09% 126
2015
Q4
Sell
-24,876
Closed -$841K 556
2015
Q3
$841K Buy
+24,876
New +$931K 0.11% 97

Other funds holding RIO

Exane Derivatives's RIO Position: Q2 2022 in Review

Exane Derivatives sold out of Rio Tinto (RIO) in Q2 2022, closing a stake of 12,892 shares — an estimated $1.04M sold.

Exane Derivatives first reported a position in RIO in Q3 2015 and held it in 16 quarters. The position peaked at $4.04M in Q4 2018. 661 funds tracked by Wall St. Rank hold RIO as of Q2 2022.

  • Exane Derivatives reported no remaining Rio Tinto position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 12,892 Rio Tinto shares in Q2 2022, an estimated $1.04M.
  • Exane Derivatives first reported a position in Rio Tinto in Q3 2015 and held it in 16 quarters.
  • Exane Derivatives's Rio Tinto position peaked at $4.04M in Q4 2018.
  • 661 funds tracked by Wall St. Rank held Rio Tinto as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.